Botanical species · safety record

Prunus domestica

The EFSA Compendium of Botanicals holds 7 constituent measurements for Prunus domestica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Prunus domestica L.

7Constituent measurements

0Safety records

4Cited sources

159Licensed products (Canada)

Also recorded as

Prunus domestica L. ssp. domestica

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 159 licensed products naming Prunus domestica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Fresh

Source material stated

Dried fruit
Fruit
Fruit Juice
Fruit concentrate
Fruit extract
Fruit fibre
Fruit flesh
Fruit skin

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Shoot	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Isoflavones	Shoot	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Amygdalin	Seed	—	1.82 Percent	Unspecified	No resolvable identifier
Amygdalin	Seed	—	—	Unspecified	No resolvable identifier
Prunasin	Seed	—	—	Unspecified	No resolvable identifier
Saponins	Fruit unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Fruit unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Kosar, Shaheen., Fatima, Itrat., Mahmood, Azhar., Ahmed, Rehana., Malik, Abdul., Talib, Sumaira., Chouhdary, Muhammad Iqbal. Purunusides A-C, alpha-Glucosidase Inhibitory Homoisoflavone Glucosides from Prunus domestica . Archives of pharmacal research, 2009, vol. 32, no. 12, p. 1705-1710. DOI
Yaqeen, Zahra., Naqvi, Naim-ul-Hassan., Imran, Hina., Fatima, Nudrat., Sohail, Tehmina., Zakir-ur-Rehman., Atiq-ur-Rahman. Evaluation of analgesic activity of P. domestica L.. Pakistan journal of pharmaceutical sciences, 2013, vol. 26, no. 1, p. 91-94.
POULTON, JE., LI, CP. TISSUE-LEVEL COMPARTMENTATION OF (R)-AMYGDALIN AND AMYGDALIN HYDROLASE PREVENTS LARGE-SCALE CYANOGENESIS IN UNDAMAGED PRUNUS SEEDS . Plant physiology, 1994, vol. 104, no. 1, p. 29-35.
Kassner, Georg., Eckelmann, K. The oil and amygdalin content of the seed kernels of Prunus domestics L.. Archiv der pharmazie (weinheim, germany), 1914, p. 402-408.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature